NCT03649763View on ClinicalTrials.gov

Onset and Duration of Forearm Nerve Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

Lidocaine

lidocaine 1%, distal ( ulnar and medial nerve): 6ml/nerve , 12m total

DRUG

Bupivacaine

Bupivacaine 0.5%,distal ( ulnar and medial nerve): 6ml/nerve , 12m total

DRUG

Lidocaine

lidocaine 1%, distal and proximal ( ulnar and medial nerve): 3ml/nerve , 12m total

Trial Locations (1)

B-3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

New York School of Regional Anesthesia

OTHER

NCT03649763 - Onset and Duration of Forearm Nerve Blockade | Biotech Hunter | Biotech Hunter